Fresenius Kabi Issues Correction for Ivenix Infusion Pumps Following Impact Damage
The Food and Drug Administration classifies the recall as the most serious type after reports of touchscreen malfunctions caused by dropped or jarred devices.
The Food and Drug Administration classifies the recall as the most serious type after reports of touchscreen malfunctions caused by dropped or jarred devices.
Inspira Technologies introduced the INSPIRA Cardi-ART, a portable modular device that provides oxygen to the brain during cardiac arrest.
Fresenius Kabi and Virginia Oncology Associates (VOA) have partnered to integrate the Ivenix Infusion System with VOA's emergency medical record, enhancing medication delivery and patient safety.
The Food and Drug Administration classifies the recall as the most serious type after reports of touchscreen malfunctions caused by dropped or jarred devices.
Supernus Pharmaceuticals plans to resubmit its application seeking approval of SPN-830, its apomorphine infusion pump for people with Parkinson’s disease, to the FDA by the end of this year.
Read MoreThe new connected Avoset Infusion System is designed with compact and simplified technology that can monitor infusion treatment data remotely.
Read MoreThe new infusion therapy council assembles prominent industry leaders to further support WeInfuse’s innovation and expansion.
Read MoreFresenius Kabi’s Ivenix Infusion System received an Innovative Technology contract from healthcare performance improvement company Vizient.
Read MoreThe reduction in duration of hospital stays and cost-of-care is driving growth of the home infusion therapy market.
Read MoreIVX Health announced two new Connecticut infusion centers in the greater New Haven and Norwalk communities.
Read More
IRadimed Corp. issued an Urgent Medical Device Correction Letter regarding a potential issue with some 1057 Syringe Adapter Sets.